Denali Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.About DNLI
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.
CEORyan J. Watts
CEORyan J. Watts
Employees422
Employees422
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2013
Founded2013
Employees422
Employees422
DNLI Key Statistics
Market cap2.37B
Market cap2.37B
Price-Earnings ratio-5.68
Price-Earnings ratio-5.68
Dividend yield—
Dividend yield—
Average volume1.64M
Average volume1.64M
High today$16.78
High today$16.78
Low today$16.00
Low today$16.00
Open price$16.17
Open price$16.17
Volume1.45M
Volume1.45M
52 Week high$33.33
52 Week high$33.33
52 Week low$10.57
52 Week low$10.57
DNLI News
TipRanks 5h
Denali Therapeutics Advances in MPS II Treatment: A Study UpdateDenali Therapeutics ((DNLI)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% o...
Analyst ratings
100%
of 18 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own DNLI. This list is generated using Robinhood data, and it’s not a recommendation.